Onpattro

patisiran · Alnylam Netherlands B.V.

Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for Onpattro, covering 2018-08-10 to 2026-07-07. Get the full timeline:

Most recent: EMA Authorised: Onpattro (patisiran sodium) — Alnylam Netherlands B.V.